Who are Efrane's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Avodart, Metofane, differin, Avodart, Levulose, Methohexitone.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/enflurane.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Efrane — Competitive Intelligence Brief

Efrane (ENFLURANE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: General Anesthetic. Area: Metabolic.

marketed General Anesthetic Glycine receptor subunit alpha-1 Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Efrane (ENFLURANE) — Baxter.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Efrane TARGET	ENFLURANE	Baxter	marketed	General Anesthetic	Glycine receptor subunit alpha-1	1972-01-01
Avodart	dutasteride	GSK (GlaxoSmithKline)	marketed	5-alpha-reductase inhibitor (dual)	3-oxo-5-alpha-steroid 4-dehydrogenase 1, 3-oxo-5-alpha-steroid 4-dehydrogenase 2, Glycine receptor subunit alpha-1	2001-11-20
Metofane	METHOXYFLURANE	Abbott	marketed	methoxyflurane	Glycine receptor subunit alpha-1, GABA-A receptor; anion channel
differin	differin	University of Magdeburg	marketed		Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha
Avodart	Avodart	GlaxoSmithKline	marketed		3-oxo-5-alpha-steroid 4-dehydrogenase 1, 3-oxo-5-alpha-steroid 4-dehydrogenase 2, Glycine receptor subunit alpha-1
Levulose	FRUCTOSE		marketed	fructose	Glycine receptor subunit alpha-1
Methohexitone	Methohexitone	St Patrick's Hospital, Ireland	marketed		Neuronal acetylcholine receptor; alpha2/beta2, Glycine receptor subunit alpha-1, GABA-A receptor alpha-1/beta-3/gamma-2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (General Anesthetic class)

Baxter · 1 drug in this class
Ph Health · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Efrane — Competitive Intelligence Brief. https://druglandscape.com/ci/enflurane. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab